Member Info for Ollieh

Great movement again and looking strong for 2024.

Good news on trials will see us back to 2018 share prices eventually.

Very impressive last month or 2.

Looks like USA liking the potential here.

Https://finance.yahoo.com/news/summit-therapeutics-announces-updated-phase-140000568.html

And another

https://finance.yahoo.com/news/laura-chow-md-cancer-immunotherapy-204100812.html

Https://www.businesswire.com/news/home/20231019060130/en/H.-Jack-West-MD-Renowned-Oncologist-Lung-Cancer-Expert-Joins-Summit-Therapeutics-as-Vice-President-of-Clinical-Development

Https://finance.yahoo.com/news/summit-therapeutics-appoints-proven-biotech-110000269.html

Rst Patient Treated in Phase III HARMONi Clinical Trial

https://finance.yahoo.com/news/summit-therapeutics-announces-first-patient-113000584.html

Nice movement again.

Summit Therapeutics Announces Initial Indications for Clinical Trials for Ivonescimab (SMT112)

https://finance.yahoo.com/news/summit-therapeutics-announces-initial-indications-123000854.html

On the road again

I should have sold a $5 ??

Will wait now for test data in China and uk.

Down premarket a lot.

Any mews?

Seeing the return to lows for a while until news on trials in UK snd China come.

Waiting game again.

https://pharmaphorum.com/news/little-summit-therapeutics-spends-big-bucks-to-rebuild-pipeline/

OK I see it's a loan from Duggan which will be payed back through a rights issue.

Given summit some breathing room.

Rns says 500m to be raised which will dilute here.

I know potential with licensing deal is huge but numbers and testing still to come.

Got me wondering I must say.

I need another 5 bucks to break even on 10k in.

But you know what...I'm waiting it out .

Wasn't worth anything a few months ago.

Looks like some profit taking before new year.
Ok here is my 2 cents.
The market knows well the dilution coming but still the sp went up.
Also we have two springboard points to come.

1st is China 3rd phase trial news to come when finished.

2nd will be our own 1st phase trial news when finished.

A while to go but think of it...if our 1st phase fda data matches China 1st phase trial data ( already published ) then the market in the west will be convinced that China data is trustworthy.

This should give the fda process a headwind as regards investor confidence.

The issue is how much dilution can this news balance out?

Don't know the numbers yet.

5.26

Yep... it can.

-28% today.

Rise couldn't last as time to start fda trial is q2 23.

Could see more downward movement until mid 23

Let's see if it drops much more.

Still going today also.

Some recovery this.

Will it hold on Friday evening...maybe